Clinical Trial: SWOG S1914

SWOG S1914

Status: Closed

A Randomized Phase III Trial of Induction/Consolidation Atezolizumab (NSC #783608) + SBRT Versus SBRT Alone in High Risk, Early Stage NSCLC

Eligible for screening study DCP 001

S1914 is closed to accrual, effective September 6, 2024